Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

33.63
+1.534.77%
Volume:3.20M
Turnover:107.16M
Market Cap:3.78B
PE:-29.16
High:34.40
Open:32.65
Low:32.16
Close:32.10
Loading ...

Viking Therapeutics Shares Down 5.1% After Co Reports Bigger-Than-Expected Q4 Loss

THOMSON REUTERS
·
06 Feb

Viking Therapeutics price target raised to $125 from $122 at Raymond James

TIPRANKS
·
06 Feb

VKTX's Q4 Loss Wider Than Expected, Sales Nil, Stock Down 10%

Zacks
·
06 Feb

Q4 2024 Viking Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
06 Feb

Has the Bubble Burst for Viking Therapeutics Stock?

Motley Fool
·
06 Feb

BUZZ-Viking Therapeutics falls as analysts call updates on obesity drug trial 'incremental'

Reuters
·
06 Feb

Viking Therapeutics Price Target Maintained With a $102.00/Share by HC Wainwright & Co.

Dow Jones
·
06 Feb

Viking Therapeutics: Strategic Advancements and Promising Outlook in Obesity Treatment Market Fuel Buy Recommendation

TIPRANKS
·
06 Feb

Viking Therapeutics Shares Down 8.2% Premarket After Co Reported Bigger-Than-Expected Q4 Loss

THOMSON REUTERS
·
06 Feb

Stock Track | Viking Therapeutics Plunges Over 9% in Pre-Market After Q4 Earnings Miss, Lack of Major Pipeline Updates

Stock Track
·
06 Feb

Viking Therapeutics Inc (VKTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...

GuruFocus.com
·
06 Feb

24H|Skyworks Solutions Sinks 22%; AMSC Soars 13%; BigBear.ai up 5% After Soaring 45% Wednesday

Tiger Newspress
·
06 Feb

Viking Therapeutics Plummeted 10% On Its Earnings Report. Here's Why.

Blockhead
·
06 Feb

Stock Track | Viking Therapeutics Plunges 10% Despite Positive Pipeline Updates on Obesity and NASH Drugs

Stock Track
·
06 Feb

Viking Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Feb

Viking Therapeutics Shares Drop After Q4 EPS Miss Estimates

Benzinga
·
06 Feb

Viking Therapeutics, Inc. (VKTX): One of January’s Biggest Losers

Insider Monkey
·
06 Feb

Stock Track | Viking Therapeutics Plunges 6.75% After-Hours Despite Positive Q4 Results and Clinical Pipeline Updates

Stock Track
·
06 Feb

Viking Therapeutics reports Q4 EPS (32c), consensus (27c)

TIPRANKS
·
06 Feb

Viking Therapeutics Q4 2024 GAAP EPS $(0.32) Misses $(0.28) Estimate

Benzinga
·
06 Feb